₹91.38 crores as of Nov 30, 2023
Age of Fund
1 years 11 months since Dec 23, 2021
0.07% as of Dec 07, 2023
Goal of Investment
Ideal holding period
Prescribed asset allocation: 95% - 100% Equity and Equity Related Securities of companies constituting Nifty 50, the Underlying Index , 0% - 5% Cash and Cash Equivalents / Money Market Instruments* with residual maturity not exceeding 91 days
Sun Pharmaceutical Industries Limited
Dr. Reddy's Laboratories Limited
Divi's Laboratories Limited
No Data to display
Tracking Error (Abs.)
Historical Returns (As per SEBI format)as of with investment of₹10,000
|This fund||NIFTY 50 TRI ^||NIFTY 50 TRI #||Tracking difference|
|CAGR||Current Value||CAGR||Current Value||CAGR||Current Value|
Income distribution Cum Capital Withdrawal (IDCW) Distributed
|Record Date||IDCW per unit||NAV Before||NAV After|
Date of allotment: Dec 23, 2021.
Period for which fund's performance has been provided is computed based on last day of the month-end preceding the date of advertisement
Since inception returns have been calculated from the date of allotment till June 30, 2021
Past performance may or may not be sustained in future and should not be used as a basis for comparison with other investments
^ Fund Benchmark # Standard Benchmark
The Scheme seeks to provide returns that, before expenses, closely correspond to the total return of the underlying index, subject to tracking errors.
There is no assurance that the investment objective of the Scheme will be realized.
An open ended scheme replicating/ tracking Nifty 50 Index.
It is to be distinctly understood that the permission given by NSE should not in any way be deemed or construed that the Scheme Information Document has been cleared or approved by NSE nor does it certify the correctness or completeness of any of the contents of the Draft Scheme Information Document. The investors are advised to refer to the Scheme Information Document for the full text of the 'Disclaimer Clause of NSE'
It is to be distinctly understood that the permission given by BSE Limited should not in any way be deemed or construed that the SID has been cleared or approved by BSE Limited nor does it certify the correctness or completeness of any of the contents of the SID. The investors are advised to refer to the SID for the full text of the Disclaimer clause of the BSE Limited